Echouffo-Tcheugui JB - Search Results

1

Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial.

Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, Sargeant LA, Williams KM, Prevost AT, Kinmonth AL, Wareham NJ, Griffin SJ. Simmons RK, et al. Lancet. 2012 Nov 17;380(9855):1741-8. doi: 10.1016/S0140-6736(12)61422-6. Epub 2012 Oct 4. Lancet. 2012. PMID: 23040422 Free PMC article. Clinical Trial.

2

The ADDITION-Cambridge trial protocol: a cluster -- randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients.

Echouffo-Tcheugui JB, Simmons RK, Williams KM, Barling RS, Prevost AT, Kinmonth AL, Wareham NJ, Griffin SJ. Echouffo-Tcheugui JB, et al. BMC Public Health. 2009 May 12;9:136. doi: 10.1186/1471-2458-9-136. BMC Public Health. 2009. PMID: 19435491 Free PMC article. Clinical Trial.

3

Long-term effect of population screening for diabetes on cardiovascular morbidity, self-rated health, and health behavior.

Echouffo-Tcheugui JB, Simmons RK, Prevost AT, Williams KM, Kinmonth AL, Wareham NJ, Griffin SJ. Echouffo-Tcheugui JB, et al. Ann Fam Med. 2015 Mar;13(2):149-57. doi: 10.1370/afm.1737. Ann Fam Med. 2015. PMID: 25755036 Free PMC article. Clinical Trial.

4

How much might cardiovascular disease risk be reduced by intensive therapy in people with screen-detected diabetes?

Echouffo-Tcheugui JB, Sargeant LA, Prevost AT, Williams KM, Barling RS, Butler R, Fanshawe T, Kinmonth AL, Wareham NJ, Griffin SJ. Echouffo-Tcheugui JB, et al. Diabet Med. 2008 Dec;25(12):1433-9. doi: 10.1111/j.1464-5491.2008.02600.x. Diabet Med. 2008. PMID: 19046242

5

Screening for type 2 diabetes: an update of the evidence.

Simmons RK, Echouffo-Tcheugui JB, Griffin SJ. Simmons RK, et al. Diabetes Obes Metab. 2010 Oct;12(10):838-44. doi: 10.1111/j.1463-1326.2010.01244.x. Diabetes Obes Metab. 2010. PMID: 20920035 Review.

6

Screening for type 2 diabetes and dysglycemia.

Echouffo-Tcheugui JB, Ali MK, Griffin SJ, Narayan KM. Echouffo-Tcheugui JB, et al. Epidemiol Rev. 2011;33:63-87. doi: 10.1093/epirev/mxq020. Epub 2011 May 30. Epidemiol Rev. 2011. PMID: 21624961 Review.

7

We should continue talking about screening for Type 2 diabetes.

Echouffo-Tcheugui JB, Sargeant LA, Griffin SJ. Echouffo-Tcheugui JB, et al. Diabet Med. 2007 Aug;24(8):924; author reply 924-5. doi: 10.1111/j.1464-5491.2007.02193.x. Diabet Med. 2007. PMID: 17650160 No abstract available.

8

Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study.

Webb DR, Gray LJ, Khunti K, Srinivasan B, Taub N, Campbell S, Barnett J, Farooqi A, Echouffo-Tcheugui JB, Griffin SJ, Wareham NJ, Davies MJ. Webb DR, et al. Diabetologia. 2011 Sep;54(9):2237-46. doi: 10.1007/s00125-011-2189-2. Epub 2011 Jun 3. Diabetologia. 2011. PMID: 21638133

9

Screening for Diabetes and Prediabetes.

Duan D, Kengne AP, Echouffo-Tcheugui JB. Duan D, et al. Endocrinol Metab Clin North Am. 2021 Sep;50(3):369-385. doi: 10.1016/j.ecl.2021.05.002. Epub 2021 Jul 12. Endocrinol Metab Clin North Am. 2021. PMID: 34399951 Free PMC article. Review.

10

The need for screening, early diagnosis, and prediction of chronic kidney disease in people with diabetes in low- and middle-income countries-a review of the current literature.

George C, Echouffo-Tcheugui JB, Jaar BG, Okpechi IG, Kengne AP. George C, et al. BMC Med. 2022 Aug 2;20(1):247. doi: 10.1186/s12916-022-02438-6. BMC Med. 2022. PMID: 35915501 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

240 results

Search Page